Imiglucerase
CAS 154248-97-2 1 FDA-DMF supplierBiologic
Overview
Imiglucerase is a recombinant DNA-engineered analogue of human β-glucocerebrosidase, an enzyme deficiency of which is associated with Gaucher's disease. It is used to catalyze the hydrolysis of glucocerebroside to glucose and ceramide.
Therapeutic areas
Genetic DisordersLysosomal Storage Disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.